ProfileGDS5822 / ILMN_2482756
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 76% 72% 71% 73% 74% 76% 66% 74% 70% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 188.376
GSM1276600PDAC Late Ablation Control 269.172
GSM1276601PDAC Late Ablation Control 379.271
GSM1276602PDAC Late Ablation 167.973
GSM1276603PDAC Late Ablation 28574
GSM1276604PDAC Late Ablation 3107.376
GSM1303940PDAC Late Ablation_anti-CTLA4 136.666
GSM1303941PDAC Late Ablation_anti-CTLA4 297.174
GSM1303942PDAC Late Ablation_anti-CTLA4 37070